Surveillance After Treatment of Oral Cancer
Part of the
Head and Neck Cancer Clinics
book series (HNCC)
Patients with cancer of the upper aero-digestive tract die from persistent or recurrent disease, second primary tumours, or intercurrent medical illness. In our experience with a cohort of 700 patients with oral cancer in the population-based tumour registry CancerCare Manitoba, 625 were treated with curative intent (R. Nason, 2010, unpublished data). Persistent disease was observed in 50 patients, the majority of whom were treated with radiotherapy (RT) as a single treatment modality. In the 575 patients that were rendered disease-free, recurrence was identified in 190 (30.4 %). The documented site of initial treatment failure was the primary site and neck in 117 and 82 patients, respectively. Distant metastases were observed at the time of initial treatment failure in 24 patients (3.8 %). Fifty-four patients (28 %) were rendered disease-free with further treatment. One hundred and fifty-seven second primary tumours were identified in 146 patients. The most frequent site was the head and neck (n = 100), followed by the lung (n = 50) and the oesophagus (n = 7). The overall and cause-specific survival at 5 years was 51 and 63 %. Overall survival by stage of disease was 74 %, 59 %, 52 % and 29 % for stages I–IV, respectively. The cause of death was documented in 336 of the 379 deaths observed in this cohort. Death was attributed to disease in 186 patients, new primary tumours in 70 and other causes in 80 patients . These parameters are consistent with most reported series of oral cancer [2–6].
KeywordsOral Cancer Asymptomatic Recurrence Speech Language Pathologist Single Treatment Modality Routine Chest Radiograph
Nason RW, Butler J. Upper aerodigestive tract carcinoma. A Canadian perspective. In: Johnson FE, Virgo KS, Margenthaler JA, et al.
(eds). Patient surveillance after cancer treatment: An international perspective
. Accepted for publication 2011.Google Scholar
Taneja C, Allen H, Koness RJ, et al.
Changing patterns in failure of head and neck cancer. Arch Otolaryngol Head Neck Surg
Carvalho AL, Magrin J, Kowalski LP. Sites of recurrence in oral and oropharyngeal cancers according to the treatment approach. Oral Diseases
Vikram B. Changing patterns of failure in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg
Dhooge IJ, De Vos M, Van Cauwenberge PB. Multiple primary malignant tumors in patients with head and neck cancer: Results of a prospective study and future perspectives. The Laryngoscope
Lippman SM, Hong WK. Second malignant tumors in head and neck squamous cell carcinoma: The overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys
Marchant FE, Lowry LD, Moffitt JJ, et al.
Current national trends in the posttreatment follow-up of patients with squamous cell carcinoma of the head and neck. Am J of Otolaryngol
Matthias AW, van Gulick JJ, Marres HA, et al.
Effectiveness of routine follow-up of patients treated for T1–2 N0 oral squamous cell carcinomas of the floor of mouth and tongue. Head Neck
Cooney TR, Poulsen MG. Is routine follow-up useful after combined-modality therapy for advanced head and neck cancer? Arch Otolaryngol Head Neck Surg
NCCN Clinical Practice Guidelines in Oncology 2008. http://www.nccn.org
Haas I, Hauser U, Ganzer U. The dilemma of follow-up in head and neck cancer patients. Eur Arch Otorhinolaryngol
De Visscher AV, Manni JJ. Routine long-term follow-up in patients treated with curative intent for squamous cell carcinoma of the larynx, pharynx, and oral cavity. Does it make sense? Arch Otolaryngol Head Neck Surg
Boysen M, Lovdal O, Tausjo J, et al.
The value of follow-up in patients treated for squamous cell carcinoma of the head and neck. Eur J Cancer
Grau JJ, Cuchi A, Trasserra J, et al.
Follow-up study in head and neck cancer: Cure rate according to tumor location and stage. Oncology
Ritoe SC, Krabbe PF, Kaanders JH, et al.
Value of routine follow-up for patients cured of laryngeal carcinoma. Cancer
Ritoe SC, Bergman H, Krabbe PFM, et al.
Cancer recurrence after total laryngectomy: Treatment options, survival, and complications. Head Neck
Ritoe SC, Verbeek ALM, Krabbe PFM, et al.
Screening for local and regional cancer recurrence in patients curatively treated for laryngeal cancer: Definition of a high-risk group and estimation of the lead time. Head Neck
Ritoe SC, Krabbe PF, Jansen MM, et al.
Screening for second primary lung cancer after treatment of laryngeal cancer. Laryngoscope
Matthias AW, Boustahji AH, Kaanders JH, et al.
A half-yearly chest radiograph for early detection of lung cancer following oral cancer. Int J Oral Maxillofac Surg
Shah SI, Applebaum EL. Lung cancer after head and neck cancer: Role of chest radiography. Laryngoscope
Van den Brekel MW, Castelijns JA, Snow GB. Diagnostic evaluation of the neck. Otolaryngol Clin North Am
Nieuwenhuis EJ, Castelijns JA, Pijpers R, et al.
Wait-and-see policy for the N0 neck in early-stage oral and oropharyngeal squamous cell carcinoma using ultrasonography-guided cytology: Is there a role for identification of the sentinel node? Head Neck
Goerres GW, Schmid DT, Bandhauer F, et al
. Positron emission tomography in the early follow-up of advanced head and neck cancer. Arch Otolaryngol Head Neck Surg
Isles MG, McConkey C, Mehanna HM. A systematic review and meta-analysis of the role of positron emission tomography in the follow-up of head and neck squamous cell carcinoma following radiotherapy or chemotherapy. Clin Otolaryngol
Cheng AC, Schmidt BL. Management of the N0 neck in oral squamous cell carcinoma. Oral Maxillofacial Surg Clin N Am